Piceatannol enhances TRAIL-induced apoptosis in human leukemia THP-1 cells through Sp1- and ERK-dependent DR5 up-regulation

Toxicology in Vitro

Volumn 25, Issue 3, 2011, Pages 605-612

  Kang, Chang Hee ^a   Moon, Dong Oh ^a   Choi, Yung Hyun ^b   Choi, Il Whan ^c   Moon, Sung Kwon ^d   Kim, Wun Jae ^e   Kim, Gi Young ^a  

^a Jeju National University   (South Korea)

^b Dong Eui University   (South Korea)

^c Inje University   (South Korea)

^d Chungju National University   (South Korea)

^e Chungbuk National University College of Medicine   (South Korea)

Author keywords

Death receptor; ERK; Piceatannol; Sp1; TRAIL

Indexed keywords

DEATH RECEPTOR 5; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PICEATANNOL; TRANSCRIPTION FACTOR SP1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMIA CELL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; DNA FRAGMENTATION; DRUG SYNERGISM; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HL-60 CELLS; HUMANS; LEUKEMIA; PHOSPHORYLATION; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; SP1 TRANSCRIPTION FACTOR; STILBENES; TNF-RELATED APOPTOSIS-INDUCING LIGAND; U937 CELLS; UP-REGULATION;

EID: 79952036939     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2010.12.006     Document Type: Article

References (37)

1. Ammann J.U., Haag C., Kasperczyk H., Debatin K.M., Fulda S. Sensitization of neuroblastoma cells for TRAIL-induced apoptosis by NF-κB inhibition. International Journal of Cancer 2009, 124:1301-1311.
2. Andrezejewski T., Deeb D., Gao X., Danyluk A., Arbab A.S., Dulchavsky S.A., Gautam S.C. Therapeutic efficacy of curcumin/TRAIL combination regimen for hormone-refractory prostate cancer. Oncology Reports 2008, 17:257-267.
3. Ashikawa K., Majumdar S., Banerjee S., Bharti A.C., Shishoda S., Aggarwal B.B. Piceatannol inhibits TNF-induced NF-κB activation and NF-κB-mediated gene expression through suppression of IκBα kinase and p65 phosphorylation. Journal of Immunology 2002, 169:6490-6497.
4. Chaudhary P.M., Eby M., Jasmin A., Bookwalter A., Murray J., HOOD L. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway. Immunity 1997, 7:821-830.
5. Chen C.Y., Tai C.J., Zheng J.J., Chen Y.Z., Liu T.Z., Yiin S.J., Chern C.L. 6-dehydrogingerdione sensitizes human hepatoblastoma Hep G2 cells to TRAIL-induced apoptosis via reactive oxygen species-mediated increase of DR5. Journal of Agricultural and Food Chemistry 2010, 58:5604-5611.
6. Chowdhury S.A., Kishino K., Satoh R., Hashimoto K., Kikuchi H., Nishikawa H., Shirataki Y., Sakagami H. Tumor-specificity and apoptosis-inducing activity of stilbenes and flavonoids. Anticancer Research 2005, 25:2055-2063.
7. Dida F., Li Y., Iwao A., Deguchi T., Azuma E., Komada Y. Resistance to TRAIL-induced apoptosis caused by constitutional phosphorylation of Akt and PTEN in acute lymphoblastic leukemia cells. Experimental Hematology 2008, 36:1343-1353.
8. Hasegawa H., Yamada Y., Komiyama K., Hayashi M., Ishibashi M., Yoshida T., Sakai T., Koyano T., Kam T.S., Murata K., Sugahara K., Tsuruda K., Akamatsu N., Tsukasaki K., Masuda M., Takasu N., Kamihira S. Dihydroflavonol BB-1, an extract of natural plant Blumea balsamifera, abrogates TRAIL resistance in leukemia cells. Blood 2006, 107:679-688.
9. Higushi H., Grambihler A., Canbay A., Bronk S.F., Gores G.J. Bile acids up-regulate death receptor 5/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1. Journal of Biological Chemistry 2004, 279:51-60.
10. Islam S., Hassan F., Mu M.M., Ito H., Koide N., Mori I., Yoshida T., Yokochi T. Piceatannol prevents lipopolysaccharides (LPS)-induced nitric oxide (NO) production and nuclear factor (NF)-κB activation by inhibiting IκB kinase (IKK). Microbiology and Immunology 2004, 48:729-736.
11. Ivanov V.N., Partridge M.A., Johnson G.E., Huang S.X., Zhou H., Hei T.K. Resveratrol sensitizes melanomas to TRAIL through modulation of antiapoptotic gene expression. Experimental Cell Research 2008, 314:1163-1176.
12. Jin C.Y., Moon D.O., Lee K.J., Kim M.O., Lee J.D., Choi Y.H., Park Y.M., Kim G.Y. Piceatannol attenuates lipopolysaccharide-induced NF-κB activation and NF-κB-related proinflammatory mediators in BV2 microglia. Pharmacological Research 2006, 54:461-467.
13. Jin C.Y., Park C., Kim G.Y., Lee S.J., Kim W.J., Choi Y.H. Genistein enhances TRAIL-induced apoptosis through inhibition of p38 MAPK signaling in human hepatocellular carcinoma Hep3B cells. Chemico-Biological Interactions 2009, 180:143-150.
14. Kim H., Kim E.H., Eom Y.W., Kim W.H., Kwon T.K., Lee S.J., Choi K.S. Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5. Cancer Research 2006, 66:1740-1750.
15. Kim M.O., Moon D.O., Kang C.H., Kwon T.K., Choi Y.H., Kim G.Y. B-Ionone enhances TRAIL-induced apoptosis in hepatoma cellular carcinoma cells through Sp1-dependent upregulation of DR5 and downregulation of NF-κB activity. Molecular Cancer Therapeutics 2010, 9:833-843.
16. Kim Y.H., Lee D.H., Jeong J.H., Guo Z.S., Lee Y.J. Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway. Biochemical Pharmacology 2008, 75:1946-1958.
17. Kim Y.H., Park C., Lee J.O., Kim G.Y., Lee W.H., Choi Y.H., Ryu C.H. Induction of apoptosis by piceatannol in human leukemic U937 cells through down-regulation of Bcl-2 and activation of caspases. Oncology Reports 2008, 19:961-967.
18. Kischkel F.C., Lawrence D.A., Chuntrarapai A., Schow P., Kim K.J., Ashkenazi A. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 2000, 12:611-620.
19. Kuo P.L., Hsu Y.L. The grape and wine constituent piceatannol inhibits proliferation of human bladder cancer cells via blocking cell cycle progression and inducing Fas/membrane bound Fas ligand-mediated apoptosis pathway. Molecular Nutrition & Food Research 2008, 52:408-418.
20. Larrosa M., Tomás-Barberán F.A., Espín J.C. The grape and wine polyphenol piceatannol is a potent inducer of apoptosis in human SK-Mel-28 melanoma cells. European Journal of Nutrition 2004, 43:275-284.
21. Lirdprapamongkol K., Sakurai H., Suzuki S., Koizumi K., Prangsaengtong O., Viriyaroj A., Ruchirawat S., Svasti J., Saiki I. Vanillin enhances TRAIL-induced apoptosis in cancer cells through inhibition of NF-κB activation. In Vivo 2010, 24:501-506.
22. Moon D.O., Kim M.O., Choi Y.H., Kim G.Y. Butein sensitizes human hepatoma cells to TRAIL-induced apoptosis via extracellular signal-regulated kinases/Sp1-dependent DR5 upregulation and NF-κB inactivation. Molecular Cancer Therapeutics 2010, 9:1583-1595.
23. Muzio M., Chinnaiyan A.M., Kischkel F.C., O'rourke K., Shevchenko A., Ni J., Scaffidi C., Bretz J.D., Zhang M., Gentz R., Mann M., Krammer P.H., Peter M.E., Dixit V.M. FLICE, a novel FADD homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996, 85:817-827.
24. Pan G., Ni J., Wei Y.F., Yu G., Gentz R., Dixit V.M. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 1997, 277:815-818.
25. Pan G., O'rourke K., Chinnaiyan A.M., Gentzy R., Ebner R., Ni J., Dixit V.M. The receptor for the cytotoxic ligand TRAIL. Science 1997, 276:111-113.
26. Raja S.M., Chen S., Yue P., Acker T.M., Lefkove B., Arbiser J.L., Khuri F.R., Sun S.Y. The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis. Molecular Cancer Therapeutics 2008, 7:2212-2223.
27. Roupe K.A., Remsberg C.M., Yanez J.A., Davies N.M. Pharmacometrics of stilbenes: segueing towards the clinic. Current Clinical Pharmacology 2006, 1:81-101.
28. Ssheridan J.P., Marsters S.A., Pitti R.M., Gurney A., Skubatch M., Baldwin D., Ramakrishnan L., Gray C.L., Baker K., Wood W.I., Gooddard A.D., Godowski P., Ashkenazi A. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 1997, 277:818-821.
29. Sprick M.R., Wwigand M.A., Riester E., Rauch C.T., Juo P., Blenis J., Krammer P.H., Walczak H. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 2000, 12:599-609.
30. Sun M., Zhang J., Liu S., Liu Y., Zhzeng D. Sp1 is involved in 8-chloro-adenosine-upregulated death receptor 5 expression in human hepatoma cells. Oncology Reports 2008, 19:177-185.
31. Takimoto R., EL-DEIRY W.S. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site. Oncogene 2008, 19:1735-1743.
32. Van Geelen C.M., De Vries E.G., De Jong S. Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy. Drug Resistance Updates 2004, 7:345-358.
33. Wiley S.R., Schooley K., Smolak P.J., Din W.S., Huang C.P., Nicholl J.K., Sutherland G.R., Smith T.D., Rauch C., Smith C.A. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995, 3:673-682.
34. Wu G.S., Burns T.F., McDonald E.R., Jiang W., Meng R., Krantz I.D., Kao G., Gan D.D., Zhou J.Y., Muschel R., Hamilton S.R., Spinner N.B., Markowitz S., Wu G., El-Deiry W.S. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nature Genetics 1997, 17:141-143.
35. Xu J., Zhou J.Y., Wei W.Z., Philipsen S., Wu G.S. Sp1-mediated TRAIL induction in chemosensitization. Cancer Research 2008, 68:6718-6726.
36. Yamaguchi H., Wang H.G. CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells. Journal of Biological Chemistry 2004, 279:45495-45502.
37. Yoshida T., Maeda A., Tani N., Sakai T. Promoter structure and transcription initiation sites of the human death receptor 5/TRAIL-R2 gene. FEBS Letters 2001, 507:381-385.